Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 38.11 M40.15 M40.16 M40.03 M42.75 M 163.09 M Research & development 11.15 M11.99 M13.12 M8.2 M10.81 M 44.12 M Operating income -9.32 M-10.19 M-8.94 M-2.16 M-6.02 M -27.31 M Non-Operating Income, Total 1.36 M1.21 M924 K1.64 M824 K 4.59 M Interest expense, net of interest capitalized 397 K537 K366 K400 K369 K 1.67 M Non-Operating Income, excl. Interest Expenses 466 K198 K281 K966 K103 K 1.55 M Unusual income/expense 500 K471 K277 K275 K352 K 1.38 M Pretax income 16.51 M16.27 M18.93 M-28.98 M20.54 M 26.76 M Equity in earnings ————— — Taxes 71.4 K-1.11 M82 K29 K102 K -893 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -8.82 M-8.71 M-8.67 M-1.85 M-5.77 M -25 M Discontinued operations ————— — Net income -8.82 M-8.71 M-8.67 M-1.85 M-5.77 M -25 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -8.82 M-8.71 M-8.67 M-1.85 M-5.77 M -25 M Basic earnings per share (Basic EPS) -0.12-0.11-0.11-0.03-0.07 -0.32 Diluted earnings per share (Diluted EPS) -0.12-0.11-0.11-0.03-0.07 -0.32 Average basic shares outstanding 73.81 M75.84 M77.34 M76.31 M78.58 M — Diluted shares outstanding 73.81 M75.84 M77.34 M76.31 M78.58 M — EBITDA -6.52 M-7.31 M-6.02 M828 K-2.91 M -15.41 M EBIT -9.32 M-10.19 M-8.94 M-2.16 M-6.02 M -27.31 M Cost of revenue 15.86 M16.52 M17 M17.33 M17.96 M 68.81 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.8 M2.88 M2.92 M2.99 M3.12 M 11.9 M